Why ? No large pharma is going to pay say 20 x our current market cap. Better a partnership deal with milestones & royalties. Partnership route is less risky for the pharma partner.
PAA - General discussions, page-52
-
- There are more pages in this discussion • 51 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.005(2.56%) |
Mkt cap ! $97.32M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 20.0¢ | 19.0¢ | $18.93K | 96.36K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 202562 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 231972 | 4 |
View Market Depth
| Last trade - 15.43pm 07/10/2024 (20 minute delay) ? |
| PAA (ASX) Chart |